Classification of patients with breast cancer according to Nottingham Prognostic Index highlights significant differences in immunohistochemical marker expression
Open Access
- 1 January 2014
- journal article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 12 (1) , 243
Abstract
Prognosis and treatment of patients with breast carcinoma of no special type (NST) is dependent on a few established parameters, such as tumor size, histological grade, lymph node stage, expression of estrogen receptor, progesterone receptor, and HER-2/neu, and proliferation index. The original Nottingham Prognostic Index (NPI) employs a three-tiered classification system that stratifies patients with breast cancer into good, moderate, and poor prognostic groups. The aim of our study was to use robust immunohistochemical methodology for determination of ER, PR, HER-2/neu, Ki-67, p53, and Bcl-2, and to observe differences in the expression of these markers when patients are stratified according to the original, three-tiered Nottingham Prognostic Index.Keywords
This publication has 29 references indexed in Scilit:
- The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysisBreast Cancer Research and Treatment, 2013
- The impact of a genomic assay (Oncotype DX) on adjuvant treatment recommendations in early breast cancerMedical Journal of Australia, 2013
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Evaluating Use Characteristics for the Oncotype Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast CancerJournal of Oncology Practice, 2013
- Prognostic influence of BCL2 expression in breast cancerInternational Journal of Cancer, 2012
- The Oncotype DX Recurrence Score Is Correlated With a Composite Index Including Routinely Reported Pathobiologic FeaturesCancer Investigation, 2010
- Breast cancer prognostic classification in the molecular era: the role of histological gradeBreast Cancer Research, 2010
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.Archives of Pathology & Laboratory Medicine, 2010
- Prognostic Significance of Nottingham Histologic Grade in Invasive Breast CarcinomaJournal of Clinical Oncology, 2008
- Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999European Journal of Cancer, 2007